drugset / Trial / NCT02533648

Role of Allopurinol on Oxidative Stress and Mitochondrial Alterations in Skeletal Muscle of Diabetic Patients

NCT02533648

Phase 3 Completed 31 enrolled Hospices Civils de Lyon
RandomizedParallel-groupDouble-blindBasic science

Summary

Our recent data in mice have demonstrated a key role of xanthine oxidase in hyperglycemia-induced by Reactive oxygen species production, and a preventive role of allopurinol (inhibitor of xanthine oxidase) on the keeping of mitochondria number and structure, in skeletal muscle of diabetic mice. The investigators want to initiate a clinical trial in order to evaluate the efficacy of allopurinol on the improvement of mitochondrial alterations, oxidative capacities and insulin sensitivity, in skeletal muscle of type 2 diabetic patients.

Timeline

Start
2011-09-16
Primary completion
2016-02
Completion
2016-02-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Allopurinol Small molecule 150 mg